Alopecia Market Size, Share, Growth Analysis, By Disease type(Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia), By Treatment(Pharmaceuticals, Devices), By Gender(Male, Female), By Sales Channel(Prescriptions, OTC), By End Use(Homecare setting, dermatology clinics), By Region - Industry Forecast 2024-2031


Report ID: SQSG35I2021 | Region: Global | Published Date: April, 2024
Pages: 165 |Tables: 141 |Figures: 78

Alopecia Market Insights

Alopecia Market size was valued at USD 2.97 billion in 2019 and is poised to grow from USD 3.21 billion in 2023 to USD 4.91 billion by 2031, growing at a CAGR of 8% in the forecast period (2024-2031).

The market for alopecia has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.

The market for treating alopecia has grown as a result of consumer demand for hair-restoration medications, many of which have increased efficacy and few negative effects. For instance, in the realm of treating alopecia, cutting-edge therapies like cytokine therapy and regenerative cell therapy are gaining popularity. Cytokine treatment promotes hair regrowth by causing hair follicle cells to specialise and proliferate while regulating the hair growth cycle. The therapeutic efficacy of combination therapy in the treatment of alopecia has also been demonstrated. The most popular hair loss treatment at the moment is combination therapies.

Over the course of the forecast period, the hair loss industry's market landscape is expected to be characterised by an increased focus on the provision of hair loss solutions (with both functional and active ingredients) with multifunctional effects, as well as by an increase in the penetration of cutting-edge hair loss treatment therapies like stem cell therapy. The number of people treated for hair loss is anticipated to increase with the advent of low-level laser therapy, which helps encourage hair growth. Additionally, the advent of laser hats, helmets, combs, and bands is anticipated to spur market expansion. The Capillus Laser Cap, iGrow Laser Helmet, iRestore Hair Growth System, and Hairmax Laser devices are a few of the cutting-edge goods available today.

US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

Market Snapshot

Global Market Size

Largest Segment

Female

Fastest Growth

Female

Growth Rate

ong>US Alopecia Market is poised to grow at a sust CAGR

Global Alopecia Market 2021-2028 ($ Bn)
Country Share for North America Region- 2021 (%)

To get more reports on the above market click here to Buy The Report

Alopecia Market Segmental Analysis

The global Alopecia market is segmented based on Disease Type, Treatment, Gender, Sales Channel, End-use and Region. Based on Disease Type the market is further sub-segmented into Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia. Based on Treatment the market is further sub-segmented into Pharmaceuticals, and Devices. Based on Gender the market is further sub segmented into Male, and Female. Based on Sales Channel the market is further sub segmented into Prescriptions, and OTC. Based on End Use the market is segregated into Homecare setting, and dermatology clinics. Based on Region the market is segregated into North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South America.

Alopecia Market Analysis by Disease Type

The market was dominated by the alopecia areata category, which had the highest revenue share (35.2%) in 2021 due to the disease's high prevalence and sufferers' increasing consumer awareness. Around 6.8 million of the approximately 147.0 million persons affected by AA live in the United States alone, according to the National Alopecia Areata Foundation. Due to an increase in the discovery of novel therapies and supportive initiatives in the approval process, the market is predicted to grow significantly over the forecast period. For instance, the US FDA granted baricitinib's Breakthrough Therapy Designation for the treatment of AA in March 2021 to Incyte Corporation and Eli Lilly and Company. The designation as a "breakthrough therapy" will speed up the approval process.

In 2021, the sector for androgenetic alopecia held the second-largest revenue share. Growing public awareness of these disorders is being fueled by proactive initiatives from groups like the American Hair Loss Association, Alopecia World, and HairMax (Lexington International), which created National Hair Loss Awareness Month. Additionally, the market expansion during the expected period is being fueled by the adoption of laser-based treatment options for AGA. Companies like Lexington Intl., LLC. (HairMax), iRestore Hair Growth System (Freedom Laser Therapy), and LUTRONIC are demonstrating cutting-edge and painless therapy solutions for treating AGA.

Over the projection period, the alopecia totalis and alopecia universalis sectors are predicted to develop at the fastest rates. The market is expected to rise during the forecast period due to rising awareness of severe forms of alopecia and an increase in research activity to discover new and efficient treatment options. Alopecia totalis and alopecia universalis affect 7 to 25% of patients with AA, according to the Genetic and Rare Diseases Information Center (GARD). Additionally, the availability of upcoming treatments for severe AA diseases, including baricitinib, deus ruxolitinib, and rociletinib, is expected to fuel the segment's expansion over the projection period..

Alopecia Market Analysis by Treatment Type

In 2021, the pharmaceutical industry dominated the market and accounted for more than 98.0 % of total sales. The segment is primarily driven by the low cost of pharmaceutical items and high consumption of prescription and over-the-counter medications. The most popular medications used to treat any form of alopecia are finasteride and minoxidil. The only medications in the United States that are licensed for the treatment of both Male Pattern Hair Loss (MPHL) and Female Pattern Hair Loss (FPHL) are finasteride and minoxidil (MPHL). Major pharmaceutical firms are also actively engaged in the discovery of novel medications to treat alopecia, which is predicted to drive the industry throughout the projection period. Examples include Lilly, Pfizer Inc., and Concert Pharmaceuticals.

During the projection period, laser-based devices used for hair regrowth are expected to experience the quickest increase. In the next 5 to 8 years, factors such as rising demand for painless treatments with few side effects and laser equipment that can be used at home will propel the market's expansion. Low-level laser therapy reduces the requirement for clinical visits while providing the convenience of at-home use. Additionally, it offers a potential non-pharmacological and non-surgical therapeutic action for hair restoration, which is predicted to cause the market to expand gradually throughout the projected time. The FDA's approval of low-level laser therapy devices like iRestore and Hairmax for the treatment of the most common types of alopecia, namely androgenetic alopecia, is expected to drive the market growth for those products during the next few years.

Alopecia Market Analysis by End Use

With a revenue share of 57.6% over the projection period, the dermatology category dominated the market. The utilisation of modern treatment techniques including laser technology, a robust product pipeline, and increased consumer awareness of the usage of prescription drugs are the key drivers of the segment's continuous growth. The consulting dermatologist is frequently regarded as the best alternative for treating alopecia due to their capacity to offer suitable personalised medications or therapy that produce positive outcomes.

Due to simplicity, usability, and patient comfort, the home care setting category will experience the fastest growth throughout the projection period. In addition, an increasing variety of home-use gadgets are receiving regulatory authorization, and non-invasive treatments like laser therapy that don't call for lifestyle adjustments are becoming more popular. For instance, the Shapiro MD hair restoration device from LifeMD, which is sold through direct-to-consumer channels and telemedicine, received FDA approval in March 2021 to encourage hair growth in men and women with androgenetic alopecia.

Alopecia Market Analysis by Gender

Due to the high prevalence of hair loss in the male population globally, the male alopecia segment led the market and generated the biggest revenue share of 53.8% in 2021. The most prevalent form of alopecia in men is androgenetic. At an average age of 50, it is believed that 50% of males have some degree of hair loss, with over 95% of cases being androgenetic in nature. Additionally, the market is expected to grow throughout the forecast period due to factors like the expanding senior population and men's increased tobacco consumption.

But over the projected period, the market for female alopecia is expected to expand at the quickest rate. The market is expected to develop as a result of greater awareness, lifestyle changes, rising PCOS rates, and a rising trend of cosmetic operations.

Alopecia Market Analysis by Sales Channel

Due to the significant number of dermatologist visits for hair loss treatment in 2021, the prescription category led the market and generated the highest revenue share of 64.9%. Around 2.6 million patients seek treatment from dermatologists for alopecia areata each year in the US, according to the National Library of Medicine. Moreover, the category is expected to develop at the quickest rate over the forecast period due to a robust product pipeline, increased disposable incomes, and an increase in the frequency of chronic conditions that ultimately cause hair loss. Whereas, the OTC segment, which is popular in developing regions and offers manufacturers a number of chances to meet the unmet medical needs of a sizable patient pool across nations like China, Japan, Mexico, Brazil, and India, is what is really driving the market. Additionally, OTC medications continue to be the preferred option of treatment for males with androgenetic alopecia and for other forms of hair loss diseases where there aren't enough approved medications, forcing patients to rely on off-label or OTC medications.

Global Alopecia Market Share By Gender, 2021 (%)

To get detailed analysis on other segments, Request For Free Sample Report

Alopecia Market Regional Insights

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

The market is expected to grow at the highest CAGR in Asia Pacific during the forecast period as a result of rising consumer awareness, disposable income, and product penetration in the region for alopecia. Additionally, it is expected that enhancing the healthcare regulatory environment in emerging nations will draw in foreign investors and open up new business opportunities. For instance, China's regulatory body, the China Food and Drug Administration, authorised the iGrow laser system by Apira Science in 2021, making it the country's first ever laser-based hair growth technology.

During the forecast period, Europe is also expected to hold a sizable market share. Many things, including technology developments and awareness programmes run by both governmental and commercial organisations, might be blamed for this surge. The European Hair Research Society plays a significant role in organising campaigns to raise awareness of hair loss research and efficient treatments for preventing hair loss.

Global Alopecia Market By Geography, 2021 - 2028
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Alopecia Market Dynamics

Alopecia Market Driver

  • The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2021. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime
  • The increasing cost of healthcare contributes to the development of the market for alopecia areata and has a significant impact on its growth rate. An increase in the number of initiatives being carried out by groups like the American Hair Loss Association and the National Alopecia Areata Foundation to spread knowledge about hair regrowth and treatment options is what is causing a rise in healthcare spending.
  • It is believed that alopecia areata, like other autoimmune disorders, has a hereditary basis and unknown triggers that result in hair loss. Disorders like multiple sclerosis, type 1 diabetes, celiac disease, rheumatoid arthritis, vitiligo, thyroid disease, and inflammatory bowel disease have all been connected to an increased risk in the patient or family.
  • The market for alopecia areata will also grow as more public and private groups launch awareness-raising campaigns. Additionally, the market for alopecia areata will grow due to increased autoimmune disease frequencies and sedentary lifestyles of individuals.

Alopecia Market Restraint

  • The high expense of the treatment, on the other hand, will impede the market's rate of expansion. The market for alopecia areata will be challenged by limited primary care services and a lack of healthcare infrastructure in emerging nations. During the projection period of 2022–2028, strong regulatory rules and a lack of public awareness will also act as inhibitors and slow down-market growth.

Request Free Customization of this report to help us to meet your business objectives.

Alopecia Market Competitive Landscape

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion.

Alopecia Market Top Player’s Company Profiles

  • Johnson & Johnson
  • Merck & Co.
  • Pfizer Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Aclaris Therapeutics, Inc.
  • Concert Pharmaceuticals, Inc.
  • HCell Inc.
  • Follica, Inc.
  • Histogen Inc.
  • Allergan plc
  • Bayer AG
  • Kythera Biopharmaceuticals, Inc.
  • Polichem S.A.
  • Takeda Pharmaceutical Company Limited
  • Almirall, S.A.
  • Perrigo Company plc
  • Vegalab, Inc.

 Alopecia Market Recent Development

  • In August 2021, Ritlecitinib's phase 2b/3 trial for alopecia areata's positive top-line results had already been made public by Pfizer. The Janus kinase 3 (JAK3) and members of the tyrosine kinase expressed in hepatocellular carcinoma (TEC) kinase family are the first targets of a new class of covalent kinase inhibitors, which include rociletinib. In laboratory tests, rociletinib was discovered to inhibit the activity of immune cells and signalling molecules that are suspected to be involved in alopecia areata patients' hair loss.

Alopecia Key Market Trends

  • Alopecia can be treated with a variety of medications and surgical procedures, including hair transplantation, scalp reduction surgery, and others. The alopecia treatment market is predicted to grow significantly over the forecast period due to factors including an increase in the incidence and prevalence of chronic diseases like arthritis, Polycystic Ovary Syndrome (PCOS), cancer, and others; a change in lifestyle and an increase in stress; an increase in the population of elderly people; hormonal imbalances and unhealthy diets; and an increase in demand for alopecia treatment drugs. Additionally, during the projected period, there is expected to be attractive market expansion prospects due to the growing areas' sizable market potential.

Alopecia Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected using Primary Exploratory Research backed by robust Secondary Desk research.

According to our analysis, the alopecia areata segment dominated the global Alopecia Market in 2021 and is expected to maintain its dominance throughout the forecast period. In 2021, North America dominated the global Alopecia Market owing to the region's increase in customer awareness and government strict regulation on plastic.

Report Metric Details
Market size value in 2031
Growth Rate ong>US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

%
Segments covered
  • Disease type
    • Alopecia Areata, Cicatricial, Traction, Androgenetic Alopecia
  • Treatment
    • Pharmaceuticals, Devices
  • Gender
    • Male, Female
  • Sales Channel
    • Prescriptions, OTC
  • End Use
    • Homecare setting, dermatology clinics
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Johnson & Johnson
  • Merck & Co.
  • Pfizer Inc.
  • Cipla Limited
  • Dr. Reddy's Laboratories Ltd.
  • Sun Pharmaceutical Industries Ltd.
  • GlaxoSmithKline plc
  • Aclaris Therapeutics, Inc.
  • Concert Pharmaceuticals, Inc.
  • HCell Inc.
  • Follica, Inc.
  • Histogen Inc.
  • Allergan plc
  • Bayer AG
  • Kythera Biopharmaceuticals, Inc.
  • Polichem S.A.
  • Takeda Pharmaceutical Company Limited
  • Almirall, S.A.
  • Perrigo Company plc
  • Vegalab, Inc.
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

Historical Year 2019

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Alopecia Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Alopecia Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Alopecia Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Alopecia Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Alopecia Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Alopecia Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW GET FREE SAMPLE
Want to customize this report?

Our industry expert will work with you to provide you with customized data in a short amount of time.

REQUEST FREE CUSTOMIZATION

FAQs

US Alopecia Market is poised to grow at a sustainable CAGR for the next forecast year.

Due to rising knowledge of alopecia treatments and increased acceptance of alopecia treatment products, Asia-Pacific offers lucrative prospects for key players operating in the alopecia treatment market. Additionally, the expansion of hospitals with cutting-edge medical facilities, and improvement in healthcare infrastructure, progress in the R&D sector, an increase in healthcare reforms, and technical developments in the healthcare industry all contribute to the market's expansion. 'Johnson & Johnson', 'Merck & Co.', 'Pfizer Inc.', 'Cipla Limited', 'Dr. Reddy's Laboratories Ltd.', 'Sun Pharmaceutical Industries Ltd.', 'GlaxoSmithKline plc', 'Aclaris Therapeutics, Inc.', 'Concert Pharmaceuticals, Inc.', 'HCell Inc.', 'Follica, Inc.', 'Histogen Inc.', 'Allergan plc', 'Bayer AG', 'Kythera Biopharmaceuticals, Inc.', 'Polichem S.A.', 'Takeda Pharmaceutical Company Limited', 'Almirall, S.A.', 'Perrigo Company plc', 'Vegalab, Inc.'

The market for alopecia areata is expected to rise as hair loss becomes more common. According to the American Academy of Dermatology Association (AAD), around 30 million women and 50 million men in the US were estimated to have alopecia in 2021. Around 60% of people experience hair thinning, with pattern hair loss being the most prevalent kind of hair loss in both men and women, according to the Journal of Clinical and Diagnostic Research (JCDR). Additionally, regardless of gender, 2% of the general population is susceptible to developing alopecia areata in their lifetime

Alopecia can be treated with a variety of medications and surgical procedures, including hair transplantation, scalp reduction surgery, and others. The alopecia treatment market is predicted to grow significantly over the forecast period due to factors including an increase in the incidence and prevalence of chronic diseases like arthritis, Polycystic Ovary Syndrome (PCOS), cancer, and others; a change in lifestyle and an increase in stress; an increase in the population of elderly people; hormonal imbalances and unhealthy diets; and an increase in demand for alopecia treatment drugs. Additionally, during the projected period, there is expected to be attractive market expansion prospects due to the growing areas' sizable market potential.

In 2021, North America dominated the market and had the highest revenue share (36.3%). High disease prevalence, rising consumer awareness, pro-active government action, technological advancements, and improvements to the healthcare system's infrastructure all contribute to the growth. A major driver of the market's expansion is the existence of important players in this area. Additionally, the region is seeing an increase in the number of people receiving laser-based therapy to treat alopecia. The National Alopecia Areata Foundation (NAAF), the Canadian Alopecia Areata Foundation, and other government and non-profit organisations that provide guidelines and raise public awareness are also likely to have a positive effect on the market.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Report ID: SQSG35I2021

$5,300
BUY NOW GET FREE SAMPLE